HK1197189A1 - Canine coronavirus vaccine - Google Patents

Canine coronavirus vaccine

Info

Publication number
HK1197189A1
HK1197189A1 HK14110797A HK14110797A HK1197189A1 HK 1197189 A1 HK1197189 A1 HK 1197189A1 HK 14110797 A HK14110797 A HK 14110797A HK 14110797 A HK14110797 A HK 14110797A HK 1197189 A1 HK1197189 A1 HK 1197189A1
Authority
HK
Hong Kong
Prior art keywords
canine coronavirus
coronavirus vaccine
vaccine
canine
coronavirus
Prior art date
Application number
HK14110797A
Other languages
English (en)
Chinese (zh)
Inventor
Nicola Decaro
Vito Martella
Gabriella Elia
Canio Buonavoglia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197189A1 publication Critical patent/HK1197189A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HK14110797A 2011-06-28 2014-10-28 Canine coronavirus vaccine HK1197189A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001182A ITMI20111182A1 (it) 2011-06-28 2011-06-28 Vaccino per coronavirus canino
PCT/EP2012/062347 WO2013000905A1 (en) 2011-06-28 2012-06-26 Canine coronavirus vaccine

Publications (1)

Publication Number Publication Date
HK1197189A1 true HK1197189A1 (en) 2015-01-09

Family

ID=44504072

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110797A HK1197189A1 (en) 2011-06-28 2014-10-28 Canine coronavirus vaccine

Country Status (10)

Country Link
US (1) US9200259B2 (xx)
EP (1) EP2726096A1 (xx)
CN (1) CN103687615A (xx)
AU (1) AU2012277893A1 (xx)
BR (1) BR112013031760A2 (xx)
CA (1) CA2839506A1 (xx)
HK (1) HK1197189A1 (xx)
IT (1) ITMI20111182A1 (xx)
MX (1) MX2013015198A (xx)
WO (1) WO2013000905A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104906542A (zh) * 2015-06-12 2015-09-16 天农大（天津）生物科技有限公司 一种治疗犬冠状病毒感染的中药组合物及其制备方法
CN109765384B (zh) * 2019-01-29 2022-11-18 北京勤邦生物技术有限公司 一种犬冠状病毒抗体荧光检测试纸条及其制备方法和应用
CN109970851B (zh) * 2019-04-01 2022-12-06 扬州大学 Ccv病毒m蛋白的单抗及其制备方法、免疫胶体金试纸条的制备方法
CN113234654B (zh) * 2021-05-06 2022-05-10 浙江大学 一种重组枯草芽孢杆菌及其应用
CN115304670A (zh) * 2021-05-07 2022-11-08 华南农业大学 一种猫冠状病毒核衣壳蛋白的鼠源单克隆抗体及其编码基因和应用
CN113817054B (zh) * 2021-10-09 2023-09-01 武汉科前生物股份有限公司 一种特异性结合猪轮状病毒vp6蛋白的鼠单克隆抗体5b11及其应用
CN115747231B (zh) * 2022-11-18 2023-08-04 西南民族大学 Ⅰ型猫冠状病毒病毒样颗粒、制备方法及应用
CN115925827B (zh) * 2022-11-30 2023-11-21 扬州大学 一种应用于检测犬冠状病毒抗体的重组m蛋白及其制备方法与应用
CN116854784B (zh) * 2023-09-05 2023-11-17 北京纳百生物科技有限公司 犬冠状病毒n蛋白抗原截短体及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
US5769047A (en) 1991-12-23 1998-06-23 Zoche; Michael Engine with oil separator
EP0640096A4 (en) * 1992-05-08 1997-01-15 Smithkline Beecham Corp UNIVERSAL CORONAVIRUS VACCINE.
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5565204A (en) 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5846547A (en) 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US6355255B1 (en) 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
PT1117435E (pt) 1998-09-30 2008-02-21 Us Gov Univ Health Sciences Holotoxina da cólera mutante como adjuvante
PT1296713E (pt) 2000-06-08 2004-02-27 Intercell Biomediz Forschungs Oligodesoxinucleotidos imunoestimuladores
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
CA2449663A1 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
AU2002322380B2 (en) 2001-06-07 2006-11-02 Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences Mutant forms of cholera holotoxin as an adjuvant
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
CA2519511A1 (en) 2003-03-17 2004-09-30 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0410220D0 (en) 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
ES2355702T3 (es) * 2005-10-26 2011-03-30 Canio Buonavoglia Coronavirus canino pantrópico.

Also Published As

Publication number Publication date
US20140205621A1 (en) 2014-07-24
BR112013031760A2 (pt) 2016-12-13
US9200259B2 (en) 2015-12-01
EP2726096A1 (en) 2014-05-07
CN103687615A (zh) 2014-03-26
WO2013000905A1 (en) 2013-01-03
AU2012277893A1 (en) 2014-01-09
ITMI20111182A1 (it) 2012-12-29
MX2013015198A (es) 2014-08-18
AU2012277893A8 (en) 2014-01-16
CA2839506A1 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
GB201005005D0 (en) New vaccine
HK1197189A1 (en) Canine coronavirus vaccine
IL231043A (en) vaccine
EP2755680A4 (en) PARTICULATE VACCINE FORMULATIONS
ZA201300395B (en) Influenza vaccine
HK1245104A1 (zh) Dna疫苗
GB201119999D0 (en) Vaccine
EP2763699A4 (en) VACCINE
PT2686011T (pt) Vacina contra npi
ZA201306245B (en) Combination vaccines
EP2771453A4 (en) DIATOM-BASED VACCINES
GB201014965D0 (en) Vaccine
IL231564A0 (en) Treatment by vaccination
ZA201404512B (en) Malaria vaccine
GB201120000D0 (en) Vaccine
GB201013006D0 (en) Vaccine
GB201006324D0 (en) Vaccine
ZA201302154B (en) Vaccine
GB201121647D0 (en) Vaccine
GB201108256D0 (en) Vaccine
GB201108982D0 (en) Vaccines
GB201108984D0 (en) Vaccines
GB201108986D0 (en) Vaccines
GB201109294D0 (en) Novel vaccine
GB201012283D0 (en) Vaccine